Natural killer cell

BIOLOGICAL2 trials

Sponsors

Yonsei University, Hong Kong Children's Hospital

Conditions

Advanced Biliary Tract CancerNeuroblastoma Recurrent

Phase 1

Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell (SMT-NK) Cell Therapy in Advanced Biliary Tract Cancer

CompletedNCT03358849

Yonsei UniversityAdvanced Biliary Tract Cancer

Start: 2017-10-17End: 2018-09-27Updated: 2019-01-16

Phase 2

Quadruple Immunotherapy for Neuroblastoma

RecruitingNCT05754684

Hong Kong Children's HospitalNeuroblastoma Recurrent

Start: 2022-01-01End: 2025-12-31Target: 29Updated: 2025-09-15